Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Biolase Q2 EPS $0.00, Sales $9.10M Beat $8.31M Estimate

Biolase (NASDAQ:BIOL) reported quarterly sales of $9.10 million which beat the analyst consensus estimate of $8.31 million by 9.51 percent. This is a 209.73 percent increase over sales of $2.94 million the same period
byBill Haddad
August 12, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Biolase (NASDAQ:BIOL) reported quarterly sales of $9.10 million which beat the analyst consensus estimate of $8.31 million by 9.51 percent. This is a 209.73 percent increase over sales of $2.94 million the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts